Immediate early genes (IEGS), including C-FOS, are integral to brain response to stimuli. Initially recognized as a first-handed, C-FOS is essential for its nervous activity, synaptic plasticity and stress reactions. While its transient expression supports memory formation in healthy brains, chronic over -expression in AD demonstrates neurotoxicity and cognitive decline. This review synthesizes the findings of posthumous studies, animal models and cell crops to clarify the double roles of the C-FOS and its mechanisms in AD pathogenesis.
Expression C-FOS in brain areas and cellular types
The C-FOS is expressed in specific areas of the brain such as hippocampus, almonds and bark, nervous activity mapping in response to stimuli. It is not limited to neurons. Gloi cells, including astrocytes and microgly, also have C-FOS induction under voltage or inflammation. In AD, the expression of global C-FOS contributes to the neuropharmoture and loss of neurons, caused by streets that include glutamate receptors and cytokines. This broad model of expression emphasizes its role in both normal and pathological conditions.
C-FOS roles in learning and memory
In healthy brains, C-FOS is vital to memory integration and synaptic plasticity. Its expression culminates during new experiences, but decreases with familiarity, reflecting adaptive nerve reactions. Disturbances in C-FOS mode damage the long-term memory, as evidenced by studies that use anti-artistic oligonucleotides. The sensitivity of C-FOS to intensity and stimulus frequency further emphasizes its role in coding and recall memories.
C-FOS induction mechanisms in learning and memory
Activation of C-FOS during learning includes glutamate signaling, NMDA receptors and later kinases such as ERK and Creb. These paths end up in the formation of the AR-1 transcription complex, which regulates genes such as ARC and BDNF, essential for synaptic plasticity. The two-phase C-FOS-Fos-Follower induction followed by the effective adjustment memory formation while preventing over-stimulation.
C-fos in Alzheimer’s disease
In AD, the expression C-FOS is abnormal, associating with amyloid-B accumulation (AB) and cognitive impairment. AB stabilizes C-FOS via O-Glcnacylation, promoting apoptosis via AP-1 and ATM3. Chronic activation C-FOS disrupts synaptic function and aggravates neuropharma, creating a vicious cycle of neurodegeneration. Studies in AD models reveal the hyperactivity of the hippocampus and the loss of neurons associated with the C-FOS hyperplasia, indicating its role in early illness indicators.
Possible C-FOS mechanisms in ad
The pathological effects of C-FOS on AD come from calcium signaling malfunction, oxidative stress and epigenetic modifications. Creb activation and mitochondrial dysfunction further perpetuate neuronal damage. The inability of the C-FOS to get used to repetitive stimuli in AD emphasizes its role in prolonged neurotoxicity and synaptic degeneration.
C-FOS and apoptosis in advertising
C-FOS promotes apoptosis via ATF3 genes and pre-transplants such as bim and cytochrome c. In ad, this path is over -activated, leading to widespread neuronal death. The ERK/FOS axis also intensifies inflammatory responses, highlighting the C-FOS as a mediator of both apoptosis and neurofemlamism.
Oxidative stress and expression c-fos in ad
Oxidative stress at AD activates the Mapk streets, adjusting the C-FOS upward and disturbing mitochondria. This exacerbates the production of ROS and the release of inflammatory cytomy, further destructive neurons. The interaction between oxidative stress and C-FOS highlights its central role in the progress of AD.
Conclusions
C-FOS has a dual role: supporting memory in healthy brains and leading neurodegeneration to AD. Its ad dysfunction includes multiple pathways, including AB toxicity, apoptosis and oxidative stress. The targeting of C-FOS configuration offers promising therapeutic pathways to alleviate cognitive decline. Future research should investigate specific C-FOS interventions to disrupt its pathological effects while maintaining its normal functions.
Source:
Magazine report:
Babaei, p., et al. (2025). C-FOS expression acts on the healthy brain compared to Alzheimer’s disease. Gene expression. Doi.org/10.14218/ge.2024.00080.